Virtus Health
- Company typePrivate
- Founded2010
- HeadquartersGreenwich, Australia
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
Virtus Health firmographics
Firmographics- Name
- Virtus Health
- Legal name
- Virtus Health Pty Ltd
- Website
- https://virtushealth.com.au
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
Virtus Health industry classification
Industry- Product category
- Assisted Reproductive Services
- NAICS
- Family Planning Centers (62141)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)
- akta.pro secondary industries
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
Keywords
Where Virtus Health is headquartered
LocationHeadquarters
- HQ city
- Greenwich
- HQ country
- Australia
- HQ region
- Oceania
Offices3 records
Markets served
Virtus Health business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Fertility and IVF Treatment Services: Virtus Health generates revenue primarily through providing assisted reproductive services including IVF, ICSI, egg freezing, embryo freezing, and related fertility treatments at its clinic network. Revenue is generated from patient treatment cycles, consultations, and procedures.
- Day Hospital Surgical Services: Revenue from operating seven specialist day hospitals across Australia supporting fertility services and other operating specialists across multiple surgical disciplines.
- Diagnostics and Pathology Services: Virtus Diagnostics provides comprehensive reproductive pathology and genetics services including genetic carrier screening, fertility blood tests, Non-Invasive Prenatal Testing (NIPT), and andrology services.
- Reproductive Genetics: Virtus Genetics provides preimplantation genetic testing, karyomapping, and reproductive genetics services.
Go-to-market motion2 records
Distribution channels14 records
Marketing channels6 records
Virtus Health product offering
Product offeringCore offering
Virtus Health operates a global network of fertility clinics providing assisted reproductive services including IVF, ICSI, egg freezing, embryo freezing, donor egg IVF, and fertility preservation, supported by comprehensive reproductive diagnostics and pathology, reproductive genetics services (PGT, karyomapping, NIPT), and seven specialist day hospitals across Australia. The company also deploys proprietary AI technology including the Ivy AI embryo selection system and AI sperm detection algorithms, and conducts translational research in antioxidant embryo culture media and whole-genome sequencing for personalized IVF dosing.
Product overview
Virtus Health is a global leader in assisted reproductive services operating as a unified portfolio of fertility clinic brands, diagnostic laboratories, and specialist day hospitals. The organization offers a comprehensive spectrum from affordable IVF (The Fertility Centre, Egg Freezing Australia) to full-service fertility treatment (IVFAustralia, Melbourne IVF, Queensland Fertility Group, TasIVF, Sims IVF, Aagaard, Trianglen, Complete Fertility, Virtus Fertility Centre Singapore) alongside specialist day hospitals, Virtus Diagnostics (NATA/RCPA/ISO accredited reproductive pathology), and Virtus Genetics. The company's technology portfolio includes the proprietary Ivy AI embryo selection system (commercially available since 2019), AI sperm detection algorithms, and a genomic sequencing initiative. Clinical research capabilities span antioxidant embryo culture media, whole-genome sequencing for IVF medication personalization, and a global RCT for AI embryo evaluation. The company helps more than 5,000 people per year become parents through 43 fertility clinics, 63 laboratories, and 7 day hospitals across 5 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Ivy Artificial Intelligence: AI-powered embryo selection technology developed in partnership with Harrison.ai and Vitrolife for improved embryo evaluation and selection in IVF treatments
- Precision Fertility Digital Platform
- Virtus Ventures
Products and services
- Fertility and IVF Treatment Services Comprehensive assisted reproductive services including IVF, ICSI, egg freezing, embryo freezing, donor egg IVF, fertility preservation, and reproductive genetics, delivered through a portfolio of fertility clinic brands (IVFAustralia, Melbourne IVF, Queensland Fertility Group, TasIVF, Sims IVF, Aagaard Fertility Clinic, Trianglen Fertility Clinic, Complete Fertility Centre, and Virtus Fertility Centre Singapore) for individuals and couples experiencing infertility.
- The Fertility Centre (Affordable IVF) Affordable IVF treatment through a simplified and standardized treatment model at locations in Brisbane, Melbourne, Liverpool, Wollongong and Gold Coast. For patients seeking quality IVF treatment at significantly lower cost than full-service fertility clinics.
- Egg Freezing Australia Specialized elective egg freezing services for women seeking to preserve fertility for future use, using vitrification method with 92% egg freezing survival rate and fertilisation rate of approximately 65% for frozen/thawed eggs similar to fresh eggs.
- Virtus Specialist Day Hospitals Seven specialist day hospitals across Australia (Alexandria, City West, North Shore, Mackay, Spring Hill, Hobart, and Melbourne IVF Procedure Centre) supporting fertility services and operating specialists in gynaecology, gastroenterology, colorectal surgery, urology, plastic surgery, ophthalmology, dental surgery, and hand surgery.
- Virtus Diagnostics Comprehensive reproductive pathology and genetics laboratory service offering genetic carrier screening, fertility blood tests (AMH, NK assay), Non-Invasive Prenatal Testing (NIPT via Panorama Screen), and advanced andrology services (SCSA, sperm DNA fragmentation, digital high magnification imaging, cryopreservation). NATA, RCPA & ISO accredited laboratories.
- Virtus Genetics Reproductive genetics service focused on genetic screening and testing, including Preimplantation Genetic Testing (PGT), karyomapping for single-gene disorders, and genetic counseling to help patients understand hereditary conditions before and during fertility treatment.
Quantifiable outcome
- Egg freezing survival rate of 92% using vitrification method
- +4 more outcomes
Companies that use Virtus Health
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Virtus Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature8 records
Virtus Health partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- Australian Netball Players' Association (ANPA)corePartnership providing elite netball athletes with free fertility health checks including pelvic ultrasound and AMH blood tests. First fertility care partnership of its kind in elite women's netball. Includes workshops, webinars, podcasts and education.
- 23StrandscoreVirtus Health invested in 23Strands, an early-stage genomics business utilizing whole genome sequencing and AI to provide better patient outcomes in IVF. Part of Virtus Ventures portfolio. 23Strands brings innovation combining data from scientific research, medical records and genetics.
- NeoGenix BiosciencescoreVirtus Health invested in NeoGenix Biosciences, a med-tech startup commercializing IVF medical devices leveraging microfluidics. AI-based sperm selection, gamete handling, gamete detection, and fertilisation platforms. Received several hundreds of thousands in in-kind commercialisation support.
- Monash UniversitycoreWorld-first study partnership with 23Strands and Monash University studying how whole genome sequencing can achieve better patient outcomes with IVF medications. Received $3 million federal government grant from MRFF. Research aims to create AI-driven tool for personally targeted dosing.
- UNSW FounderscoreVirtus Health and UNSW Founders partnered to launch a dedicated Women's Health stream of the Health 10x Accelerator program. First initiative of Virtus Ventures. Aims to equip startups with business expertise and resources for health technology ecosystem understanding and commercialization.
- The George Institute for Global HealthcoreCo-created Health 10x Accelerator program focused on women's health innovation, created by UNSW Founders and The George Institute for Global Health.
- Ronde MediacoreVirtus Health opened clinic doors to Ronde Media for production of 'Big Miracles' docu-series on Channel 9. The series follows real patients through IVF journeys, filmed exclusively in Virtus clinics. Multiple seasons produced.
- University of MelbournecoreResearch collaboration for antioxidant embryo culture media development. Professor David Gardner conducted lab research at University of Melbourne leading to clinical trials.
- University of Technology Sydney (UTS)minorAI sperm selection research collaboration with UTS Warkiani Lab. Study carried out at IVFAustralia and in the Warkiani Lab, UTS.
- Drop BiominorCollaboration with Drop Bio aiming to track and explain the critical role that chronic inflammation plays in the success of ARS. Drop Bio is an Australian biotechnology and digital health company.
- CooperSurgicalcoreCollaboration announced with CooperSurgical, a leading international provider of fertility and genomic solutions, for advancing reproductive technology capabilities.
- VitrolifecoreTransfer and collaboration agreements with Vitrolife for Ivy AI system development. The Ivy AI technology for embryo evaluation was developed in partnership with Harrison.ai and Vitrolife.
- Harrison.aicoreDevelopment partner for Ivy AI system - artificial intelligence for embryo evaluation. Harrison.ai developed the AI algorithm for comprehensive embryo assessment.
Scale indicators9 records
Recent moves10 records
Expansion highlights6 records
Virtus Health competitors and assessment
Company assessmentOthers
- Vitrolife: Swedish-listed developer of IVF media, time-lapse incubators, and lab equipment, and a co-development partner for Virtus's Ivy AI. Comparable as the leading upstream technology partner in the ART lab, supplying EmbryoScope+ and culture media to the broader industry.
Direct peers
- Monash IVF Group: Australia's largest dedicated fertility clinic network, also ASX-listed until recently. Direct competitor to Virtus's IVFAustralia, Melbourne IVF, and Queensland Fertility Group across the Australian market with overlapping service lines in IVF, ICSI, and PGT.
- Care Fertility: UK fertility clinic network offering IVF, ICSI, PGT, and egg/sperm donation. Comparable in size and product range to Virtus's Complete Fertility Centre in the UK south coast and a meaningful regional competitor in the British market.
- Genea: Sydney-headquartered fertility clinic group (formerly Sydney IVF) operating across Australia. Direct competitor in IVF and reproductive genetics, with comparable investments in time-lapse embryo culture and AI-based embryo assessment.
- Bourn Hall Clinic: UK fertility clinic network founded by the original IVF pioneers. Direct UK competitor to Virtus's Complete Fertility Centre with overlapping NHS and private service offerings and similar focus on clinical success rates.
- IVI-RMA Global: World's largest assisted reproduction group (KKR-backed) operating across Europe, Latin America, and now the US. Directly comparable to Virtus as a multi-country fertility clinic platform with significant investment in reproductive genetics and laboratory technology.
- The Fertility Partnership: European fertility clinic network operating in the UK, Ireland, Spain, and the Nordics. Direct competitor to Virtus's Sims IVF in Ireland and to its UK and Danish clinics, with similar tiered premium and value sub-brands.
- TFP Fertility: Pan-European fertility clinic group (UK, Poland, Netherlands, Czech Republic, Germany). Highly comparable to Virtus as a multi-country ART roll-up with day hospital and diagnostics adjacencies.
Broad incumbents
- CooperSurgical: US-headquartered leader in fertility and genomic solutions, partnered with Virtus since 2021. Not a direct clinic competitor but the dominant supplier of ART consumables, devices, and PGT services globally; comparable as a broad incumbent in the fertility value chain.
Regional players
- Prelude Network (Inception Fertility): Largest US fertility clinic network (a subsidiary of Inception Fertility). Not a direct competitor given Virtus's US exclusion, but the closest US analog in scale, brand portfolio breadth, and multi-site operating model — useful as a US TAM benchmark.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Virtus Health social profiles
Digital presenceVirtus Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Virtus Health leadership team
Management profileNumber of profiles
Profiles17 records
Virtus Health subsidiaries and ownership
Company hierarchySubsidiaries13 records
Virtus Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Virtus Health M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Virtus Health
What does Virtus Health do?
Virtus Health operates a global network of fertility clinics providing assisted reproductive services including IVF, ICSI, egg freezing, embryo freezing, donor egg IVF, and fertility preservation, supported by comprehensive reproductive diagnostics and pathology, reproductive genetics services (PGT, karyomapping, NIPT), and seven specialist day hospitals across Australia. The company also deploys proprietary AI technology including the Ivy AI embryo selection system and AI sperm detection algorithms, and conducts translational research in antioxidant embryo culture media and whole-genome sequencing for personalized IVF dosing.
Is Virtus Health a public or private company?
Virtus Health is a private company. It is classified as private equity controlled and is currently operating.
When was Virtus Health founded?
Virtus Health was founded in 2010. It employs 1,001 to 5,000 people.
Where is Virtus Health based?
Virtus Health is headquartered in Greenwich, Australia, in the Oceania region.
How does Virtus Health make money?
Four revenue lines are on record. Fertility and IVF Treatment Services are the primary driver. The others are day Hospital Surgical Services, diagnostics and Pathology Services and reproductive Genetics.
Who are Virtus Health's main competitors?
Vitrolife is listed as an others. Direct peers are Monash IVF Group, Care Fertility, Genea, Bourn Hall Clinic, IVI-RMA Global, The Fertility Partnership and TFP Fertility. CooperSurgical is listed as a broad incumbent. Prelude Network (Inception Fertility) is listed as a regional player.
Does Virtus Health have an API?
No public API is recorded for Virtus Health.
What industry is Virtus Health in?
Virtus Health's product category is Assisted Reproductive Services. Its primary akta.pro industry code is HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility), with a secondary code of HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers. Its NAICS code is 62141 and its SIC code is 8011.